The global non-invasive brain stimulation system market size is calculated at USD 701.14 million in 2024, grew to USD 748.82 million in 2025, and is predicted to hit around USD 1,353.69 million by 2034, poised to grow at a CAGR of 6.8% between 2024 and 2034. The Asia Pacific non-invasive brain stimulation system market size accounted for USD 217.35 million in 2024 and is anticipated to grow at the fastest CAGR of 6.97% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Non-invasive Brain Stimulation System Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Non-invasive Brain Stimulation System Market Revenue and Volume, by Product, 2024-2034
8.1.1 Transcranial Magnetic Stimulation (TMS) System
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Transcranial Current Stimulation (TCS) System
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Non-invasive Brain Stimulation System Market Revenue and Volume, by End-user, 2024-2034
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Specialty Clinics
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Non-invasive Brain Stimulation System Market Revenue and Volume, by Application, 2024-2034
10.1.1. Depression
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Epilepsy
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Parkinson's Disease
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Chronic Pain
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1. Brainbox Ltd.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BrainsWay
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. eNeura Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Magnus Medical, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Magstim
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. MagVenture
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. NeoSync, Inc. (Wave Neuroscience, Inc.)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. NeuraLace
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Neurocare Group AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Flow Neuroscience
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample